These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3476675

  • 1. Three tumor sensitivity tests evaluated with mouse tumors.
    Lelieveld P, Mulder JH.
    Int J Cell Cloning; 1987 Jul; 5(4):335-46. PubMed ID: 3476675
    [Abstract] [Full Text] [Related]

  • 2. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T, Kuraishi Y, Aiba K, Inoue K.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [Abstract] [Full Text] [Related]

  • 3. [Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein].
    Nishiyama M, Noso Y, Yamaguchi M, Hirabayashi N, Toge T, Niimoto M, Hattori T.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):275-9. PubMed ID: 3080963
    [Abstract] [Full Text] [Related]

  • 4. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
    Fodstad O, Aamdal S, Pihl A, Boyd MR.
    Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
    [Abstract] [Full Text] [Related]

  • 5. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R, Koessler AK, Howel SB.
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro chemotherapy sensitivity testing for human kidney tumor lines: a comparative study.
    Kurth KH, Romijn JC, Kappendijk M, Weissglas MG, van Dongen JW.
    Semin Surg Oncol; 1988 May; 4(2):103-9. PubMed ID: 3393774
    [Abstract] [Full Text] [Related]

  • 7. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N, Morimoto H, Akita T, Inoue H, Tanaka T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [Abstract] [Full Text] [Related]

  • 8. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
    Noso Y, Niimi K, Nishiyama M, Hirabayashi N, Toge T, Niimoto M, Hattori T.
    Cancer Res; 1987 Dec 01; 47(23):6418-22. PubMed ID: 3677085
    [Abstract] [Full Text] [Related]

  • 9. Human tumor testsystems: a new screening approach.
    Kraemer HP, Sedlacek HH.
    Behring Inst Mitt; 1986 Jun 01; (80):103-12. PubMed ID: 3753367
    [Abstract] [Full Text] [Related]

  • 10. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.
    Zaffaroni N, Silvestrini R, Grignolio E, Villa R, DeMarco C.
    Int J Cell Cloning; 1988 Nov 01; 6(6):392-403. PubMed ID: 2466088
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of the chemosensitivity test by subrenal capsule assay].
    Terashima M, Ikeda K, Satoh M, Ishida K, Yoshida H, Mori S, Inada K, Yoshida M.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 1):653-8. PubMed ID: 2435246
    [Abstract] [Full Text] [Related]

  • 12. [Chemotherapy responsiveness of brain tumors in subrenal capsule assay].
    Miyamachi K.
    Hokkaido Igaku Zasshi; 1990 Jan 01; 65(1):41-9. PubMed ID: 2328945
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of the chemosensitivity test by human tumor clonogenic assay and subrenal capsule assay].
    Terashima M.
    Nihon Geka Gakkai Zasshi; 1987 Nov 01; 88(11):1554-64. PubMed ID: 3431536
    [Abstract] [Full Text] [Related]

  • 14. Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.
    Aschele C, Romanini A, Nicolin A, Rosso R, Sobrero A.
    Anticancer Res; 1990 Nov 01; 10(3):759-64. PubMed ID: 2195987
    [Abstract] [Full Text] [Related]

  • 15. [In vitro sensitivity of human tumor xenografts to cytotoxic drugs in soft agar clonogenic assay].
    Mizuno Y, Satomura K, Tanaka K, Hashimura T, Tanigawa N.
    Nihon Gan Chiryo Gakkai Shi; 1985 May 20; 20(4):735-43. PubMed ID: 4056548
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ, Basic I, Milas L.
    Cancer Res; 1985 May 20; 45(5):2025-30. PubMed ID: 4039220
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic aspects of in vitro and in vivo chemosensitivity tests.
    Isobe Y, Kubota T, Asanuma F, Kurihara H, Inada T, Fukutomi T, Ishibiki K, Abe O.
    Jpn J Cancer Res; 1987 Sep 20; 78(9):983-90. PubMed ID: 3117754
    [Abstract] [Full Text] [Related]

  • 18. [A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
    Fukui H, Ide H, Hanyu F, Ikemoto H, Okushima N, Murata Y, Sato Y, Yamada A.
    Gan To Kagaku Ryoho; 1987 Apr 20; 14(4):1106-10. PubMed ID: 2436579
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 20; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacodynamic study of the in vitro clonogenic assay--with reference to dose levels].
    Isobe Y.
    Nihon Geka Gakkai Zasshi; 1988 Oct 20; 89(10):1594-602. PubMed ID: 3200235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.